Testing effectiveness (Phase 2)Study completedNCT02605967
What this trial is testing
Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Carcinoma
Novartis Pharmaceuticals 122